Orchid Pharma Limited (ORCHPHARMA)
Statement of Deviation or variation for the quarter ended June 30, 2026 on the use of proceeds of Funds raised through Qualified Institutional Placement.
Statement of deviation on use of QIP proceeds for quarter ended June 30, 2026
- QIP funds raised Rs 400 Cr on June 27, 2023
- Deviation due to postponement of new block at API Facility, Alathur
- Shareholders approved reallocation of funds on Sep 20, 2025
- Investment focus shifted to Jammu manufacturing facility; commercial operations expected Feb 2027
- Full utilization of funds as per revised schedule; monitoring agency Care Ratings Limited reviewed
- Delay in land acquisition and construction at Jammu facility noted
- Repayment of borrowings and general corporate purposes funded as planned
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 ORCHPHARMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add ORCHPHARMA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Orchid Pharma Limited
Important.
The summary above is generated automatically from Orchid Pharma Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.